FDA’s FY 2027 budget request previews agency priorities, reduced appropriated funding

By Laura DiAngelo, MPH

The FDA’s fiscal year 2027 budget request outlines a shift in how the agency plans to fund and prioritize its work, with continued reliance on user fees alongside constrained appropriated funding. The request highlights key operational priorities, including maintaining user fee programs, expanding inspection capabilities and investing in infrastructure and advanced manufacturing.

The proposal also reflects broader administration priorities, including efforts tied to food policy, artificial intelligence, and regulatory modernization, while raising questions about funding levels, staffing and implementation.

This AgencyIQ analysis examines what the budget request reveals about FDA’s evolving priorities and what it could mean for regulated industries.

Fill out the form to read the full analysis.